We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Survival-related profile, pathways, and transcription factors in ovarian cancer.
- Authors
Crijns, Anne P G; Fehrmann, Rudolf S N; de Jong, Steven; Gerbens, Frans; Meersma, Gert Jan; Klip, Harry G; Hollema, Harry; Hofstra, Robert M W; te Meerman, Gerard J; de Vries, Elisabeth G E; van der Zee, Ate G J
- Abstract
Ovarian cancer has a poor prognosis due to advanced stage at presentation and either intrinsic or acquired resistance to classic cytotoxic drugs such as platinum and taxoids. Recent large clinical trials with different combinations and sequences of classic cytotoxic drugs indicate that further significant improvement in prognosis by this type of drugs is not to be expected. Currently a large number of drugs, targeting dysregulated molecular pathways in cancer cells have been developed and are introduced in the clinic. A major challenge is to identify those patients who will benefit from drugs targeting these specific dysregulated pathways.The aims of our study were (1) to develop a gene expression profile associated with overall survival in advanced stage serous ovarian cancer, (2) to assess the association of pathways and transcription factors with overall survival, and (3) to validate our identified profile and pathways/transcription factors in an independent set of ovarian cancers.
- Publication
PLoS medicine, 2009, Vol 6, Issue 2, pe24
- ISSN
1549-1676
- Publication type
Journal Article
- DOI
10.1371/journal.pmed.1000024